Navigation Links
Dendreon Announces Data Presentations and Webcast at AUA Annual Meeting
Date:4/24/2009

SEATTLE, April 24 /PRNewswire-FirstCall/ -- Dendreon Corporation (Nasdaq: DNDN) today announced the following data presentations taking place at the American Urological Association's (AUA) Annual Meeting in Chicago, as well as a Dendreon-sponsored IMPACT data webcast conference call:

  • April 28, 2009, 2:20 p.m. CDT - "A randomized, double-blind, placebo-controlled, multi-center, phase III trial of sipuleucel-T in men with metastatic, androgen independent prostatic adenocarcinoma (AIPC)." AUA Late-Breaking Science Forum to be held from 1:00 p.m. to 2:30 p.m. CDT. Room W375 at McCormick Place
  • April 28, 2009, 10:30 a.m. to 12:30 p.m. CDT - Abstract #1408: "Preclinical Evaluation of the TRPM8 Ion Channel Agonist D-3263 for Benign Prostatic Hyperplasia." Poster presentation to occur in the Benign Prostatic Hyperplasia: Basic Research session. Room W375B at McCormick Place
  • April 28, 2009, 4:30 p.m. CDT - IMPACT data webcast conference call

The IMPACT (IMmunotherapy for Prostate AdenoCarcinoma Treatment) study evaluated PROVENGE(R) (sipuleucel-T), Dendreon's investigational product candidate for men with advanced prostate cancer representing the first in a new class of active cellular immunotherapies specifically designed to engage the patient's own immune system against cancer. Dendreon announced last week that the IMPACT trial met its primary endpoint of improving overall survival compared to a placebo control.

To access the live conference call, dial 1-877-675-4753 (domestic) or 719-325-4864 (international). The call also will be audio webcast and will be available from the Company's website at www.dendreon.com under the "Investor/Webcast
'/>"/>

SOURCE Dendreon Corporation
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Dendreon Announces Data on PROVENGE Potency and Long-Term Immune Responses in Androgen-Dependent Prostate Cancer
2. Dendreon Reports Fourth Quarter and 2008 Year End Financial Results
3. Dendreon Announces Webcast Presentation at Eleventh Annual BIO CEO & Investor Conference
4. Dendreon Announces Webcast Presentation at 27th Annual J.P. Morgan Healthcare Conference
5. Dendreon Reports Third Quarter 2008 Financial Results
6. Dendreon Announces Webcast Presentations at Upcoming Investor Conferences
7. Dendreon Presents Preclinical Data Validating Anti-Tumor Activity of D-3263, a Trp-p8 Agonist
8. Dendreon Announces Webcast Presentation at UBS Global Life Sciences Conference
9. Dendreon Announces Webcast Presentation at Newsmakers in the Biotech Industry Conference
10. Dendreon Initiates Second of Two New Phase 2 Trials of PROVENGE for Prostate Cancer
11. Dendreon Reports First Quarter 2008 Financial Results

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/9/2009)... Nov. 9 BioMed Realty Tr...ompany has received commitments from lenders to in...e of credit by $65 million to an aggregate of $665...e facility. The weighted-average effective intere...as of September 30, 2009. The maturity date remain...
(Date:11/9/2009)... Nov. 9 NexBio, Inc. announced the...can College of Allergy, Asthma, and Immunology in ...S181 (Fludase®), a Sialidase, Decreases Airwa...cts in Animal Models of Asthma". ,, DAS181 (Flu... host-targeting drug candidate being studied in hu...
(Date:11/9/2009)... Product release is a research industry f...rch facilities and research safety study data to b... Cedar Knolls, NJ (PRWEB) November ...that it has unveiled Pristima™ VM, an integr...ilities that track the use and care of veterinary ...
(Date:11/8/2009)...N VIEW, Calif. Nov. 5, 2009 Complete Genomics, a... today announced publication of a report in the jo...uencing platform, including analysis of sequence d...bles cost for these three genomes sequenced on the...from $8,005 for 87x coverage to $1,726 for 45x cov...
Breaking Biology Technology:BioMed Realty Trust Receives Commitments to Expand Unsecured Line of Credit to $665 Million 2BioMed Realty Trust Receives Commitments to Expand Unsecured Line of Credit to $665 Million 3NexBio(R) Presents Data Showing Anti-Asthma Activity of DAS181 (Fludase(R)*) at ACAAI 2009 2NexBio(R) Presents Data Showing Anti-Asthma Activity of DAS181 (Fludase(R)*) at ACAAI 2009 3Xybion Unveils Pristima™ VM, an Integrated Enterprise Software Solution for Vivarium and Veterinary Care Management 2Complete Genomics publishes in Science on low-cost sequencing of 3 human genomes 2
...., March 4 Vermillion, Inc.,(Nasdaq: VRMLD ), a ...ecent,accomplishments across its diagnostic test p...estones it plans to achieve over the course of 200... the fourth quarter and year,ended December 31, 20...al and commercial,advancements in our diagnostic p...
... 4 On Wednesday, March 5, 2008,at 8:30 a.m. Easte...me,members of Cell Therapeutics, Inc.,s (CTI) (Nas...ost a conference call to discuss the company,s rec... structure, and upcoming,product and sales milesto...bers Wednesday, March 5...
...E, Fla., March 4 Imaging,Diagnostic Systems, Inc....tical breast imaging systems, will exhibit CT Lase...uropean Congress of Radiology (ECR 2008), March,7-...xpo E #566., (Logo: http://www.newscom.com/cgi-b...be a part of ECR 2008," commented Deborah O,Brien,...
Other Biology Technology:Vermillion Summarizes Recent Accomplishments and 2007 Financial Results; Outlines 2008 Business Milestones 2Vermillion Summarizes Recent Accomplishments and 2007 Financial Results; Outlines 2008 Business Milestones 3Vermillion Summarizes Recent Accomplishments and 2007 Financial Results; Outlines 2008 Business Milestones 4Vermillion Summarizes Recent Accomplishments and 2007 Financial Results; Outlines 2008 Business Milestones 5Vermillion Summarizes Recent Accomplishments and 2007 Financial Results; Outlines 2008 Business Milestones 6Vermillion Summarizes Recent Accomplishments and 2007 Financial Results; Outlines 2008 Business Milestones 7Vermillion Summarizes Recent Accomplishments and 2007 Financial Results; Outlines 2008 Business Milestones 8Vermillion Summarizes Recent Accomplishments and 2007 Financial Results; Outlines 2008 Business Milestones 9Cell Therapeutics, Inc. to Hold Conference Call to Update on Recent Transactions and Upcoming Milestones 2CT Laser Mammography Technology to be Featured at European Congress of Radiology 2
(Date:11/9/2009)...turwissenschaften is publishing a special issue "...gy" to commemorate Darwin,s On the Origin of Speci...859. Guest editor and author of the lead article i...ogy and evolutionary biology at the University of ...sue are available free of charge until 30 December...
(Date:11/9/2009)...ponsible for the rapid, mysterious death of phytop... by collaborating scientists at Rutgers University...I). This same chemical may hold unexpected promis...eviously unknown lipid, or fatty compound, in a vi... huxleyi , a phytoplankton that plays a major role...
(Date:11/8/2009)...IGNED FOR ADULTS WITH INTELLECTUAL DISABILITIES: A...University study involving adults with intellectua...ir personal health knowledge after taking a semi-w...n internationally accepted term for mental retarda...cal inactivity and preventable chronic diseases co...
Breaking Biology News(10 mins):Newly discovered fat molecule: An undersea killer with an upside 2Newly discovered fat molecule: An undersea killer with an upside 3Newly discovered fat molecule: An undersea killer with an upside 4Indiana U. at APHA: Studies about health education for people with ID, stability balls at work 2Indiana U. at APHA: Studies about health education for people with ID, stability balls at work 3Prestigious 244 9 million NIH grant awarded to Case Western Reserve for colon cancer research 10077 1Prestigious 244 9 million NIH grant awarded to Case Western Reserve for colon cancer research 10077 2RetireSafe to Senate 3A Stop Proposed Rationing of High Quality Hospital Care Medicare Needs More Physician Hospitals 58219 1RetireSafe to Senate 3A Stop Proposed Rationing of High Quality Hospital Care Medicare Needs More Physician Hospitals 58219 2Physician Reimbursement and Their Practice Survival Defended by American National Medical Management 58214 1Physician Reimbursement and Their Practice Survival Defended by American National Medical Management 58214 2
...er 100 scientists worldwide publish joint study in...a, Asia, Europe and the US have been probing the g...l years. Their results in some aspects have comple...ns. The findings are available in the prestigious ...lusion of the study is that the genome of mammals ...
...w insects avoid getting diseases they can carry an...sas State University. , Mike Kanost, university di...the department of biochemistry, and researchers in...es against infection. They think the answer lies i...searchers have made progress in understanding whic...
...study published in the latest issue of Restoration...eefs help to deter erosion. Oyster reefs are self...se they use native materials, have the potential f...system stability and quality. , Oyster larvae move... oysters, settlement; reefs are therefore able to ...
Other Biology News:Mouse genome much more complex than expected 2K-State researchers study insects' immune system 2
... Rotofor purification system with PowerPac 3000 po...ion and purification by liquid-phase isoelectric f...18 ml) and standard (60 ml) focusing chambers, cha...ode chambers, PowerPac 3000 power supply, 10 ml Bi...
Anti-Connexin 45 (Cx45), Near C-terminus, cytoplasmic Monoclonal Antibody, Unconjugated, Clone 5B9.2 from CHEMICON
NBT/BCIP Chromogen System (SIGNET) from Covance Research Products, Inc
... Infinite 200 series of microplate readers combine...ce or absorbance detection in an affordable, easy-...ence applications. The unique modular design and a...searchers with a choice of a monochromator (M200) ...
Biology Products: